Jianerkang Medical Co., Ltd. (SHA:603205)

Jianerkang Medical Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	1,071	1,042	1,032	1,090	780.16	1,615
Other Revenue	4.02	4.02	1.4	2.77	1.88	8.5
Revenue	1,075	1,046	1,034	1,093	782.04	1,623
Revenue Growth (YoY)	-1.69%	1.18%	-5.46%	39.79%	-51.83%	116.77%
Cost of Revenue	828.69	812.39	802.61	834.8	600.08	881.01
Gross Profit	246.09	233.37	230.92	258.43	181.97	742.47
Selling, General & Admin	66.4	62.87	54.31	57.13	51.42	101.57
Research & Development	42.18	40.72	36.59	35.3	28.64	51
Other Operating Expenses	9.41	9.62	7.89	9.09	6.43	11.46
Operating Expenses	121.46	112.73	104.73	116.07	80.98	154.99
Operating Income	124.62	120.64	126.18	142.36	100.98	587.48
Interest Expense	-0.01	-0.01	-0.65	-1.66	-2.07	-11.76
Interest & Investment Income	8.51	7.61	4.35	2.67	0.45	4.22
Currency Exchange Gain (Loss)	6.29	6.29	8.67	28.55	-7.17	-19.75
Other Non Operating Income (Expenses)	-1.01	-0.2	-0.25	-0.23	-0.45	-0.56
EBT Excluding Unusual Items	138.41	134.34	138.31	171.69	91.74	559.64
Gain (Loss) on Sale of Investments	0.33	-	-16.68	-	-	-
Gain (Loss) on Sale of Assets	0.43	0.43	0.03	-3.02	0.13	0
Asset Writedown	0.06	-0.07	-0.07	-0.07	-0.12	-37.72
Other Unusual Items	2.78	2.78	20.68	9.24	57.88	4.98
Pretax Income	142.23	137.69	142.62	177.83	149.63	526.9
Income Tax Expense	18.16	17.48	19.08	20.49	18	142.64
Net Income	124.07	120.22	123.55	157.34	131.63	384.26
Net Income to Common	124.07	120.22	123.55	157.34	131.63	384.26
Net Income Growth	-21.14%	-2.69%	-21.48%	19.53%	-65.75%	457.65%
Shares Outstanding (Basic)	102	95	90	90	90	80
Shares Outstanding (Diluted)	102	95	90	90	90	80
Shares Change (YoY)	13.76%	4.97%	0.20%	-0.00%	12.43%	9.21%
EPS (Basic)	1.21	1.27	1.37	1.75	1.46	4.80
EPS (Diluted)	1.21	1.27	1.37	1.75	1.46	4.80
EPS Growth	-30.68%	-7.30%	-21.63%	19.54%	-69.53%	410.64%
Free Cash Flow	74.78	101.35	73.62	96.7	21.96	370.05
Free Cash Flow Per Share	0.73	1.07	0.82	1.07	0.24	4.62
Dividend Per Share	0.351	0.351	-	-	-	-
Gross Margin	22.90%	22.32%	22.34%	23.64%	23.27%	45.73%
Operating Margin	11.59%	11.54%	12.21%	13.02%	12.91%	36.19%
Profit Margin	11.54%	11.50%	11.95%	14.39%	16.83%	23.67%
Free Cash Flow Margin	6.96%	9.69%	7.12%	8.85%	2.81%	22.79%
EBITDA	167.5	163.13	167.13	179.2	133.4	594.06
EBITDA Margin	15.58%	15.60%	16.17%	16.39%	17.06%	36.59%
D&A For EBITDA	42.88	42.49	40.95	36.84	32.41	6.59
EBIT	124.62	120.64	126.18	142.36	100.98	587.48
EBIT Margin	11.59%	11.54%	12.21%	13.02%	12.91%	36.19%
Effective Tax Rate	12.77%	12.69%	13.38%	11.52%	12.03%	27.07%
Revenue as Reported	1,075	1,046	1,034	1,093	782.04	1,623
Advertising Expenses	-	3.14	2.16	2.84	3.15	1.98

Source: S&P Global Market Intelligence. Standard template. Financial Sources.